Lepodisiran, a long-duration small interfering RNA, reduces lipoprotein(a) levels
1. Lepodisiran, a long-duration small interfering RNA targeting lipoprotein(a) synthesis, reduced serum concentrations of lipoprotein(a) compared to placebo in adults...